DYRK1B and fatty liver disease: However, Dyrk1b–/– mice on HCD were not protected against hyperlipidemia or hepatic steatosis (Supplemental Figure 7, A and B), in contrast to Dyrk1bAAV-shRNA mice (Figure 3, E–G).